1. Applicants must complete all sections of the application form.

2. Applicants must be able to clearly provide details on their proposed program of activity whether it is a new idea, a program that is underway or one that is to be expanded. The application should highlight why the proposed activity is innovative and how it addresses one or more of the key objectives for the Grants program.

3. Applications should only address areas not provided for by the Australian National Immunisation Program and all programs should be based in Australia.

4. Budgets should not include items currently reimbursed by the MBS.

5. It is expected that the proposed activity could be implemented in other settings and sustained after the Grant funding ceases.

6. Entries will be accepted from a GP in solo or a group practice, Divisions of General Practice, General Practice Networks, Medicare Locals Councils/Local Authorities, Hospitals, Community and Indigenous Health organisations and will be allocated accordingly to the appropriate category.

7. Applications must be for programs of activity that can be up and running within a 12-month period. The presentation at the 2013 AGPN meeting should be a final report.

8. Applications must be for programs of activity that can be set up with a Grant of $20,000.

The total value of the grant is $20,000. These monies will be provided to the recipient in two instalments: $15,000 shortly after the announcement of the successful applicant, to enable the project to commence, and the remaining $5,000 9 months later, in conjunction with the presentation of a brief progress report.

Applicants may use additional funding from other sources (excluding other industry sponsors) however this must be declared and must be approved in writing by the other source prior to the application closing date.

Please note that these Grants are intended to support innovative programs demonstrating best practice in adult immunisation in Australia. They are not intended for the funding of human subject research in the form of studies.

 
Human subject research involves addressing a predefined research question, and measuring biomedical and/or health outcomes either with or without a defined intervention. These studies may have interventional, observational, health outcomes or epidemiological designs (prospective or retrospective).

 
If you are considering an application that you feel may fall into this category or if you would like further guidance, please contact Dr Neil Formica, GSK Medical Advisor (mobile 0424 096490 or email neil.t.formica@gsk.com ).